Harvard Medical School, Massachusetts General Hospital, Weight Center at Massachusetts General Hospital, Boston, MA, USA.
Vanderbilt University Medical Center, Nashville, TN, USA.
Pediatr Clin North Am. 2024 Oct;71(5):957-980. doi: 10.1016/j.pcl.2024.07.006.
The recent advent of highly effective anti-obesity medications (AOM) provides pediatric clinicians a powerful tool to augment the treatment of obesity and improve outcomes. The 2023 American Academy of Pediatrics guidelines state clinicians "should offer adolescents 12 years and older with obesity weight loss pharmacotherapy, according to medication indications, risks, and benefits, as an adjunct to health behavior and lifestyle treatment". This article will provide an update on the integration of AOM into practice, emphasizing clinical pearls and practical tips.
最近出现了非常有效的抗肥胖药物 (AOM),为儿科临床医生提供了一种强大的工具,可增强肥胖症的治疗效果并改善治疗结果。2023 年美国儿科学会指南指出,“根据药物的适应证、风险和益处,临床医生应为 12 岁及以上肥胖的青少年提供减肥药物治疗,作为健康行为和生活方式治疗的辅助手段”。本文将重点介绍临床要点和实用技巧,提供有关将 AOM 融入实践的最新信息。